Yogesh Jeelall
Australian National University
16 Papers
7 Citations
Yogesh Jeelall is an academic researcher from Australian National University. The author has contributed to research in topics: B cell & Diffuse large B-cell lymphoma. The author has an hindex of 10, co-authored 15 publications. Previous affiliations of Yogesh Jeelall include University of Western Australia & Harry Perkins Institute of Medical Research.
Chat about Author
Papers
Phospho-tuning immunity through Denisovan, modern human and mouse TNFAIP3 gene variants
Nathan W. Zammit,Owen M. Siggs,Owen M. Siggs,Paul Gray,Paul Gray,Keisuke Horikawa,Stephen R. Daley,David B. Langley,Daniele Cultrone,Elisabeth K. Malle,Stacey N. Walters,Jeanette E. Villanueva,Joanna Warren,Amanda J. Russell,Mark J. Cowley,Mark J. Cowley,Velimir Gayevskiy,Marcel E. Dinger,Marcel E. Dinger,Claudia Loetsch,Cecile King,Robert Brink,David Zahra,Geeta Chaudhri,Gunasegaran Karupiah,Belinda Whittle,Carla M. Roots,Edward M. Bertram,Michiko Yamada,Yogesh Jeelall,Anselm Enders,Benjamin E. Clifton,Peter D. Mabbitt,Colin J. Jackson,Susan R. Watson,Craig N. Jenne,Lewis L. Lanier,Tim Wiltshire,Matthew H. Spitzer,Garry P. Nolan,Frank Schmitz,Alan Aderem,Benjamin T. Porebski,Ashley M. Buckle,Derek W. Abbott,John B. Ziegler,John B. Ziegler,Maria E. Craig,Maria E. Craig,Paul Z. Benitez-Aguirre,Juliana Teo,Melanie Wong,Murray P. Cox,Wilson Phung,Ingrid E. Wertz,Daniel Christ,Daniel Christ,Christopher C. Goodnow,Christopher C. Goodnow,Shane T. Grey,Shane T. Grey +60 more
TL;DR: Genetic analyses of anatomically modern humans, extinct Denisovan hominins, and mice revealed a series of missense variants in the immune response inhibitor A20, substituting non-catalytic residues of the ubiquitin protease domain to diminish IκB-dependent phosphorylation and activation of A20.
Ascia-p44: assessing the utility of the basophil activation test for the diagnosis of suspected anaesthetic or antibiotic allergy in a western australian cohort
Joel Kidman,Christine Bundell,P. H. M. Sadleir,Yogesh Jeelall,Elizabeth Fisher,Michael O'Sullivan,R. C. Clarke,Peter R. Platt,Delia J. Nelson,Andrew McLean-Tooke,Michaela Lucas +10 more
2
Genetics of Disease Progression in Diffuse Large B-Cell Lymphoma: Clonal Selection and Acquisition of Newly Acquired Somatic Mutations at Relapse
Dipti Talaulikar,Dipti Talaulikar,Yogesh Jeelall,Andrew Ziolkowski,Matthew C. Cook,Matthew C. Cook,Sanjiv Jain,Sanjiv Jain,Dan Andrews,Matthew A. Field,Christopher C. Goodnow +10 more
TL;DR: While multiple IGHV sub-clones are present at diagnosis of DLBCL, evolution of a single clone is noted at relapse (convergent model) with acquisition of additional somatic mutations.
1
CARD11 gain-of-function mutation drives cell-autonomous accumulation of PD-1+ ICOShigh activated T cells, T-follicular, T-regulatory and T-follicular regulatory cells
Etienne Masle-Farquhar,Yogesh Jeelall,Jacqueline White,Julia Bier,Elissa K. Deenick,R. Brink,Keisuke Horikawa,Christopher C. Goodnow +7 more
TL;DR: In this article , a Germline Card11 gain-of-function (GOF) mutation was found to cause B cell Expansion with NF-κB and T cell Anergy (BENTA) disease, whilst somatic GOF CARD11 mutations recur in diffuse large B cell lymphoma (DLBCL) and in up to 30% of the peripheral T cell lymphomas (PTCL) adult T cell leukemia/lymphoma (ATL), cutaneous T cell cancer (CTCL) and Sezary Syndrome.
The role of immunological testing and intervention in reproductive medicine: A fertile collaboration?
Syed Ali,Yogesh Jeelall,Yogesh Jeelall,Craig E. Pennell,Roger Hart,Roger Hart,Andrew McLean-Tooke,Michaela Lucas +7 more
TL;DR: A systematic review examines the published evidence on immune changes in patients, the use of immunomodulation therapies and diagnostic testing modalities to guide their use or to identify patient subsets most likely to benefit and the need to advance immunological diagnostics.